In the past few years, the GDP in the region has been majorly derived by the health care sector and it has provided many benefits to the health care stock in return. During 2010, 96% was the total return from the health care industry which included only two other sectors that consumer and technology. Health insurers and care providers were the managing some of the major winners in these years which returned the Affordable Care Act. Other strong performers include medical and biotech device companies. In the next decades, it is expected that this trend will continue with more enhanced GDP growth in most of the OECD countries by the health care spending in next years, which will increase the health spending per capita from 8.8% in 2018 to about 10.2% of GDP in 2030. The Medicare and Medicaid Services Office of the Actuary projects in the US that will increase GDP from 17.9% in 2017 to 19.4% in 2027 and derived by an increase in prices and old age people of the community. A Sweden based health care fund, to Rhenman & Partners Asset Management, which was established in 2008 by CIO Henrik Rhenman, is one of the popular names in the health care sector. The external experts give scientific advice and fundamental analysis used in the funds to evaluate the stock in the healthcare market around the world. This article covers Best 5 Large-Cap Healthcare Stocks for 2021.
Cigna Corporation is one of the names in this sector. The second half of our list begins with Cigna Corporation, as 140,000 shares of CI have been owned by Rhenman & Partners Asset Management on 30th December and during Q4 they sold 10,000 shares. The healthcare stocks of Humana and many other hedge fund ownerships of Cigna during Q3 decreased to 14%. It does not include the Billionaire investing icon Leon Cooperman, as during the CNBC interview in December he pitched the stock and admired it for its good history and low forwards P/E. In 2020, its revenue was adjusted by Cigna to 14% and EPS was adjusted to 18.45 dollar. Last year, he raised his Medicare Advantage membership by 18%. Another name is Eli Lilly and Company. 10,000 shares of Eli Lilly and company were bought by Rhenman & Partners Asset Management during Q4 and raised its shares holding to 180,000 by 30 December which valued at $30.39 million. At the beginning of November, LLY has gained most of the shares such that it gained 50% of the shares. Read more about these companies at Top 10 Large-Cap Healthcare Stocks to Buy Now.